Ten-year follow-up of basiliximab induction therapy for live-donor kidney transplant: a prospective randomized controlled study.
Sheashaa, Hussein A; Bakr, Mohamed A; Rashad, Rashad H; Ismail, Amani M; Sobh, Mohamed A; Ghoneim, Mohamed A.
Exp Clin Transplant
; 9(4): 247-51, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21819369
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
Preformed donor HLA-DP-specific antibodies mediate acute and chronic antibody-mediated rejection following renal transplantation.
Acceptability of older adults as living kidney donors.
Simultaneous liver-kidney transplantation: shifting renal allograft gene expression from inflammation toward preservation.
Resultados a largo plazo en trasplante renal de donantes con criterios expandidos.
Steroid avoidance or withdrawal for kidney transplant recipients.
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.
Antibiotics for asymptomatic bacteriuria in kidney transplant recipients.
Current status of costimulatory blockade in renal transplantation.